MICHAEL RAAB
CIK 1321402 · President & CEO · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.11M
Companies
4
Total Filings
120
Lifetime Open-Market Net
-$8.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | President & CEO | 1,776,351 | $5.69 | $10.11M | -$8.12M | 83 | 2026-05-22 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | -$629.0K | 28 | 2026-04-27 |
| TPST | Director | — | $1.26 | — | $0 | 6 | 2026-01-28 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | — | — | — | $0 | 3 | 2008-03-31 |
Recent Filings · Page 8 of 12
120 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-14 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +10,115 | $0 | EDGAR |
| 2021-05-21 | ARDX | Sell (S) | −2,534 | -$18.0K | EDGAR |
| 2021-05-20 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Exer (M) | +5,634 | $42.6K | EDGAR |
| 2021-02-24 | ARDX | Sell (S) | −2,534 | -$17.4K | EDGAR |
| 2021-01-07 | ARDX | Grant (A) | +115,102 | $0 | EDGAR |
| 2020-09-17 | ARDX | Sell (S) | −106,337 | -$596.3K | EDGAR |
| 2020-07-06 | ARDX | Sell (S) | −23,128 | -$162.1K | EDGAR |
| 2020-06-12 | ARDX | Other (J) | +1,235 | $0 | EDGAR |
| 2020-06-08 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +5,855 | $0 | EDGAR |
| 2020-06-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | — | -$49.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.